Association Redetection of Regular Insulin and NPH Insulin using Statistical Features

被引:0
|
作者
Kamble, Anupriya K. [1 ]
Manza, Ramesh R. [1 ]
Rajput, Yogesh M. [1 ]
Hannan, Shaikh Abdul [2 ]
机构
[1] Dr Babasaheb Ambedkar Marathwada Univ, Dept Comp Sci & IT, Aurangabad, MS, India
[2] Al Baha Univ, Dept Comp Sci, Albaha, Saudi Arabia
关键词
Statistical; BGL; Regular Insulin Dose; NPH Insulin Dose;
D O I
暂无
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Diabetes Mellitus (DM), commonly referred as diabetes is a disorder that most of the people suffer from and which also leads to death many of the times. Type 1, Type 2 and Gestational diabetes are the types of diabetes. The present study is of patients suffering from Type 1 DM. In Type 1 diabetes a patient has to take external insulin to maintain the blood glucose level (BGL). Insulin is a hormone produced in the pancreas which maintains the BGL of a person. BGL is responsible for a person's daily activity. Within a specified target range the blood glucose level has to be maintained. Thus the blood glucose monitoring helps one to link between blood glucose, food, exercise and insulin. The readings of the blood glucose level determine the best management strategy for diabetes. The complications occurring in diabetes reduces by maintaining good blood glucose control. Four to five types of insulin are available in which our focus is on Regular insulin and NPH insulin. Regular insulin is a short acting insulin and NPH insulin is an intermediate acting insulin. The association detection of first fifteen patients by doing statistical study has already been done in which no association was found. This study has been done on the next fifteen patients dataset, to verify same result are obtained or result differs from it.
引用
收藏
页码:59 / 62
页数:4
相关论文
共 50 条
  • [1] WHICH IS FIRST - REGULAR INSULIN OR NPH
    SELDERS, NJ
    RN MAGAZINE, 1985, 48 (02): : 74 - 74
  • [2] PHARMACOKINETICS OF REGULAR AND NPH INSULIN IN DIABETICS WITH INSULIN-ANTIBODIES
    NITIYANANT, W
    WENDORFF, H
    CHOU, MCY
    FIELD, JB
    CLINICAL RESEARCH, 1977, 25 (03): : A522 - A522
  • [3] MISCIBILITY OF HUMAN SEMISYNTHETIC REGULAR AND LENTE INSULIN AND HUMAN BIOSYNTHETIC REGULAR AND NPH INSULIN
    OLSSON, PO
    HANS, A
    HENNING, VS
    DIABETES CARE, 1987, 10 (04) : 473 - 477
  • [4] EFFECT OF NPH INSULIN ON THE TIME-COURSE OF ACTION OF REGULAR INSULIN
    PETERS, AL
    DAVIDSON, MB
    CLINICAL RESEARCH, 1988, 36 (01): : A191 - A191
  • [5] MISCIBILITY OF HUMAN SEMISYNTHETIC REGULAR AND LENTE INSULIN (ACTRAPID HUMAN MONOTARD HUMAN) AND HUMAN BIOSYNTHETIC REGULAR AND NPH INSULIN (HUMULIN REGULAR/NPH)
    OLSSON, PO
    ARNQVIST, H
    VONSCHENCK, H
    ACTA ENDOCRINOLOGICA, 1986, 112 : 41 - 41
  • [6] TIME ACTION CHARACTERISTICS OF REGULAR AND NPH INSULIN IN INSULIN-TREATED DIABETICS
    ROY, B
    CHOU, MCY
    FIELD, JB
    DIABETES, 1978, 27 : 439 - 439
  • [7] EFFECT OF STORAGE ON ACTION OF NPH AND REGULAR INSULIN MIXTURES
    PETERS, AL
    DAVIDSON, MB
    DIABETES CARE, 1987, 10 (06) : 799 - 800
  • [8] Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes
    Sargin, H
    Sargin, M
    Altuntas, Y
    Sengül, AM
    Orbay, E
    Seber, S
    Uçak, S
    Yayla, A
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 62 (02) : 79 - 86
  • [9] TIME-ACTION CHARACTERISTICS OF REGULAR AND NPH INSULIN IN INSULIN-TREATED DIABETICS
    ROY, B
    CHOU, MCY
    FIELD, JB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (03): : 475 - 479
  • [10] NPH INSULIN
    KORBY, GJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1954, 154 (08): : 728 - 728